ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease (CAD-AAA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01897623
Recruitment Status : Completed
First Posted : July 12, 2013
Last Update Posted : December 17, 2014
Sponsor:
Collaborators:
Kuopio University Hospital
Tampere University Hospital
Information provided by (Responsible Party):
Ville Vänni, North Karelia Central Hospital

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.


Condition or disease Intervention/treatment Phase
Abdominal Aortic Aneurysm Other: ultrasound of aorta Not Applicable

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Primary Purpose: Screening
Official Title: Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
Study Start Date : July 2013
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
ultrasound of aorta Other: ultrasound of aorta


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound [ Time Frame: upon screening ]

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Male patients with coronary artery disease

Exclusion Criteria:

  • Patient's denial to participate
  • Female Gender
  • Already diagnosed or treated abdominal aortic aneurysm
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01897623


Locations
Finland
North Carelia Central Hospital
Joensuu, Pohjois-Karjala, Finland, 80200
Sponsors and Collaborators
North Karelia Central Hospital
Kuopio University Hospital
Tampere University Hospital
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Ville Vänni, General surgeon, North Karelia Central Hospital
ClinicalTrials.gov Identifier: NCT01897623     History of Changes
Other Study ID Numbers: AAA-CAD-02
First Posted: July 12, 2013    Key Record Dates
Last Update Posted: December 17, 2014
Last Verified: December 2014

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Aneurysm
Aortic Aneurysm
Aortic Aneurysm, Abdominal
 Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Aortic Diseases